US stock · Healthcare sector · Drug Manufacturers—General
Company Logo

AbbVie Inc.

ABBVNYSE

137.56

USD
-1.06
(-0.76%)
Market Closed
31.99P/E
12Forward P/E
1.33P/E to S&P500
242.696BMarket CAP
4.17%Div Yield
Scale: |
View:
Currency: USD, in millions
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
Income Statement
Revenue
14,214
15,638
17,444
18,380
18,790
19,960
22,859
25,638
28,216
32,753
33,266
45,804
56,197
58,054
COGS
4,056
4,293
4,639
4,508
4,581
4,426
4,500
5,833
7,040
7,718
7,439
15,387
17,446
17,414
Gross Profit
10,158
11,345
12,805
13,872
14,209
15,534
18,359
19,805
21,176
25,035
25,827
30,417
38,751
40,640
Gross Profit Ratio
71.46%
72.55%
73.40%
75.47%
75.62%
77.83%
80.31%
77.25%
75.05%
76.44%
77.64%
66.41%
68.96%
70.00%
Operating Expenses
5,056
6,628
8,511
8,055
8,545
12,123
10,822
10,421
11,584
18,652
12,844
17,856
19,865
21,826
R&D Expenses
1,707
2,808
2,618
3,066
3,193
3,649
4,435
4,566
5,309
10,753
6,792
6,557
7,084
6,510
Selling, G&A Exp.
3,349
3,820
5,894
4,989
5,352
7,724
6,387
5,855
6,275
7,399
6,942
11,299
12,349
15,260
General and Admin. Exp.
3,349
3,820
5,894
4,989
5,352
7,724
6,387
5,855
6,275
7,399
6,942
- -
- -
- -
Selling and Marketing Exp.
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Expenses
- -
- -
- -
- -
- -
750
- -
- -
- -
500
(890)
- -
432
56
COGS and Expenses
9,112
10,921
13,151
12,563
13,126
16,549
15,322
16,254
18,624
26,370
20,283
33,243
37,311
39,240
Interest Income
- -
28
- -
20
21
38
33
82
146
204
275
174
39
- -
Interest Expense
- -
- -
- -
104
299
429
719
1,047
1,150
1,348
1,784
2,454
2,423
(2,044)
Depreciation and Amortization
697
1,184
1,272
1,150
897
786
836
1,189
1,501
1,765
2,017
6,471
8,521
8,467
EBITDA
6,648
6,020
4,941
6,979
6,528
3,584
8,200
10,120
10,378
8,310
12,227
12,317
23,926
19,891
EBITDA ratio
46.77%
38.50%
28.32%
37.97%
34.74%
17.96%
35.87%
39.47%
36.78%
25.37%
36.76%
26.89%
42.58%
34.26%
Operating Income
4,932
4,717
3,621
5,817
5,664
3,411
7,537
9,384
9,592
6,383
12,983
11,363
17,924
18,814
Operating Income ratio
34.70%
30.16%
20.76%
31.65%
30.14%
17.09%
32.97%
36.60%
33.99%
19.49%
39.03%
24.81%
31.89%
32.41%
Total Other Income Exp.(Gains)
1,019
119
48
(92)
(332)
(1,042)
(892)
(1,500)
(1,865)
(1,186)
(4,557)
(7,965)
(4,935)
(5,337)
Income Before Tax
5,950
4,836
3,669
5,725
5,332
2,369
6,645
7,884
7,727
5,197
8,426
3,398
12,989
13,477
Income Before Tax ratio
41.86%
30.92%
21.03%
31.15%
28.38%
11.87%
29.07%
30.75%
27.39%
15.87%
25.33%
7.42%
23.11%
23.21%
Income Tax Expense (Gain)
1,314
658
235
450
1,204
595
1,501
1,931
2,418
(490)
544
(1,224)
1,440
1,632
Net Income
4,637
4,178
3,433
5,275
4,128
1,774
5,144
5,953
5,309
5,687
7,882
4,616
11,542
11,836
Net Income Ratio
32.62%
26.72%
19.68%
28.70%
21.97%
8.89%
22.50%
23.22%
18.82%
17.36%
23.69%
10.08%
20.54%
20.39%
EPS
2.93
2.64
2.17
3.35
2.60
1.11
3.20
3.74
3.33
3.85
5.33
2.62
6.53
6.69
EPS Diluted
2.93
2.64
2.17
3.35
2.56
1.10
3.13
3.63
3.30
3.66
5.28
2.62
6.45
6.63
Weighted Avg. Shares Outs.
1,580
1,580
1,580
1,577
1,587
1,591
1,610
1,593
1,592
1,479
1,479
1,765
1,768
1,771
Weighted Avg. Shares Outs. Dil.
1,580
1,580
1,580
1,577
1,604
1,610
1,637
1,631
1,603
1,546
1,484
1,765
1,777
1,778
Balance Sheet
Cash and Cash Equivalents
- -
10
27
5,901
9,595
8,348
8,399
5,100
9,303
7,289
39,924
8,449
9,746
9,201
Short-Term Investments
- -
1
626
2,075
300
26
8
1,323
486
772
- -
30
84
28
Cash & Short-Term Investments
- -
11
654
7,976
9,895
8,374
8,407
6,423
9,789
8,061
39,924
8,479
9,830
9,229
Net Receivables
- -
3,373
3,817
4,298
4,803
4,291
4,730
4,758
5,088
5,384
5,428
8,822
9,977
11,254
Inventory
- -
836
872
1,091
1,150
1,124
1,719
1,444
1,605
1,605
1,813
3,310
3,128
3,579
Other Current Assets
- -
3,998
2,012
1,989
2,000
2,299
1,458
3,562
4,741
1,895
2,354
3,562
4,993
4,401
Total Current Assets
- -
8,218
7,354
15,354
17,848
16,088
16,314
16,187
21,223
16,945
49,519
24,173
27,928
28,463
PP&E
- -
2,358
2,144
2,247
2,298
2,485
2,565
2,604
2,803
2,883
2,962
5,248
5,110
4,935
Goodwill
- -
6,197
6,100
6,130
6,277
5,862
13,168
15,416
15,785
15,663
15,604
33,124
32,379
32,156
Intangible Assets
- -
3,691
2,910
2,323
1,890
1,513
19,709
28,897
27,559
21,233
18,649
82,876
75,951
67,439
Goodwill and Intangible Assets
- -
9,888
9,010
8,453
8,167
7,375
32,877
44,313
43,344
36,896
34,253
116,000
108,330
99,595
Investments
- -
137
229
119
118
92
145
1,783
2,090
1,420
93
293
277
241
Tax Assets
- -
533
920
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Non-Current Assets
- -
- -
- -
835
767
1,507
1,149
1,212
1,326
1,208
2,288
4,851
4,884
5,571
Total Non-Current Assets
- -
12,916
12,303
11,654
11,350
11,459
36,736
49,912
49,563
42,407
39,596
126,392
118,601
110,342
Other Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
- -
21,135
19,657
27,008
29,198
27,547
53,050
66,099
70,786
59,352
89,115
150,565
146,529
138,805
Accounts Payable
- -
357
417
556
933
881
1,597
1,407
1,474
1,546
1,452
2,276
2,882
- -
Short-Term Debt
- -
- -
- -
1,042
431
4,446
2,431
402
6,415
5,308
3,753
8,502
12,495
4,136
Tax Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Current Liabilities
- -
3,404
5,480
5,178
5,515
6,073
6,866
7,972
8,752
10,385
10,380
17,883
19,817
25,402
Total Current Liabilities
- -
3,761
5,897
6,776
6,879
11,400
10,894
9,781
16,641
17,239
15,585
28,661
35,194
29,538
Long-Term Debt
- -
- -
- -
14,630
14,292
10,565
29,240
36,440
30,953
35,002
62,975
77,554
64,189
59,135
Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Deferred Tax Liabilities
- -
- -
- -
360
570
630
5,276
6,890
2,490
1,067
1,130
3,646
3,009
2,190
Other Non-Current Liabilities
- -
1,670
1,537
1,879
2,965
3,210
3,695
8,352
15,605
14,490
17,597
27,607
28,701
30,655
Total Non-Current Liabilities
- -
1,670
1,537
16,869
17,827
14,405
38,211
51,682
49,048
50,559
81,702
108,807
95,899
91,980
Other Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Lease Obligations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Liabilities
- -
5,432
7,433
23,645
24,706
25,805
49,105
61,463
65,689
67,798
97,287
137,468
131,093
121,518
Preferred Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Common Stock
- -
- -
- -
3,713
16
16
17
18
18
18
18
18
18
18
Retained Earnings
- -
- -
- -
- -
1,567
535
2,248
4,378
5,459
3,368
4,717
1,055
3,127
4,784
Other Compreh. Income(Loss)
- -
288
(25)
(350)
(442)
(2,031)
(2,561)
(2,586)
(2,727)
(2,480)
(3,596)
(3,117)
(2,899)
(2,199)
Other Total Stockhold. Equity
- -
15,415
12,249
- -
3,351
3,222
4,241
2,826
2,347
(9,352)
(9,311)
15,120
15,162
14,651
Total Stockholders Equity
- -
15,703
12,224
3,363
4,492
1,742
3,945
4,636
5,097
(8,446)
(8,172)
13,076
15,408
17,254
Total Liab.&Stockhold. Equity
- -
21,135
19,657
27,008
29,198
27,547
53,050
66,099
70,786
59,352
89,115
150,544
146,501
138,772
Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Liabilities & Equity
- -
21,135
19,657
27,008
29,198
27,547
53,050
66,099
70,786
59,352
89,115
150,544
146,501
138,772
Cash Flow Statement
Net Income
4,637
4,178
3,433
5,275
4,128
1,774
5,144
5,953
5,309
5,687
7,882
4,622
11,549
11,845
Depreciation and Amortization
697
1,184
1,272
1,150
897
786
836
1,189
1,501
1,765
2,017
6,471
8,521
8,467
Deferred Income Tax
- -
- -
- -
- -
- -
- -
- -
- -
1,242
424
- -
(2,325)
(898)
(1,931)
Stock Based Compensation
157
167
163
187
212
241
282
353
365
421
430
753
692
671
Change in Working Capital
504
(866)
706
(621)
658
(788)
504
(1,689)
9
(1,126)
(1,329)
106
(1,322)
5,891
Accounts Receivable
(322)
(60)
(498)
223
- -
- -
- -
(71)
(391)
(591)
(74)
(929)
(1,321)
(1,455)
Inventory
165
(73)
(88)
(203)
(56)
(203)
(434)
(38)
93
(226)
(231)
(40)
(142)
(686)
Accounts Payable
210
(695)
1,497
(731)
(426)
(193)
1,503
(1,187)
425
190
(1,121)
1,514
1,628
1,605
Other Working Capital
- -
4,457
1,457
8,578
10,969
4,688
5,420
6,406
4,582
(294)
33,934
(573)
(1,290)
- -
Other Non-Cash Items
(627)
313
673
354
372
1,536
769
1,235
1,534
6,256
4,324
7,961
4,235
- -
Cash Provided by Operating Activities
5,367
4,976
6,247
6,345
6,267
3,549
7,535
7,041
9,960
13,427
13,324
17,588
22,777
24,943
CAPEX
(313)
(448)
(356)
(333)
(491)
(612)
(532)
(479)
(529)
(638)
(552)
(798)
(787)
(695)
Acquisitions Net
(170)
(2,621)
(273)
(688)
(405)
(622)
(12,452)
(2,757)
(308)
(736)
(1,135)
(39,610)
(1,902)
(255)
Purchases of Investments
(4)
(93)
(1,943)
(2,550)
(930)
(1,169)
(851)
(5,315)
(2,230)
(1,792)
(583)
(61)
(119)
(1,438)
Sales/Maturities of Investments
0
1
1,255
1,153
2,705
1,477
880
2,359
2,793
2,160
2,699
1,525
98
1,530
Other Investing Activities
0
(1,870)
1,870
- -
- -
- -
19
118
- -
- -
167
1,387
366
235
Cash Used for Investing Activities
(486)
(5,031)
554
(2,418)
879
(926)
(12,936)
(6,074)
(274)
(1,006)
596
(37,557)
(2,344)
(623)
Debt Repayment
(35)
- -
(21)
- -
- -
- -
(4,018)
(6,010)
(25)
(6,035)
(5,235)
(5,683)
(9,414)
(14,433)
Common Stock Issued
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Common Stock Repurchased
- -
- -
- -
- -
(320)
(652)
(7,567)
(6,033)
(1,410)
(12,014)
(629)
(978)
(934)
(1,487)
Dividends Paid
- -
- -
- -
- -
(2,555)
(2,661)
(3,294)
(3,717)
(4,107)
(5,580)
(6,366)
(7,716)
(9,261)
(10,043)
Other Financing Activities
(4,846)
65
(6,762)
1,931
(567)
20
20,631
11,832
30
9,233
30,938
2,876
570
1,160
Cash Used/Provided by Financing Activities
(4,881)
65
(6,783)
1,931
(3,442)
(3,293)
5,752
(3,928)
(5,512)
(14,396)
18,708
(11,501)
(19,039)
(24,803)
Effect of Forex Changes on Cash
- -
- -
- -
16
(10)
(577)
(300)
(338)
29
(39)
7
(5)
(97)
(62)
Net Change In Cash
(0)
65
18
5,874
3,694
(1,247)
51
(3,299)
4,203
(2,014)
32,635
(31,475)
1,297
(545)
Cash at the End of Period
0
10
27
5,901
9,595
8,348
8,399
5,100
9,303
7,289
39,924
8,449
9,746
9,201
Cash at the Beginning of Period
0
- -
10
27
5,901
9,595
8,348
8,399
5,100
9,303
7,289
39,924
8,449
9,746
Free Cash Flow
5,055
4,528
5,891
6,012
5,776
2,937
7,003
6,562
9,431
12,789
12,772
16,790
21,990
24,248
Forex Rate
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -